ERIN KILEY: Open Payments
NPI 1720748767 · MADISON HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,361 in 144 payments from 15 companies in 2025. Trend: 2023 $1,501 · 2024 $1,498 · 2025 $2,361
Food & beverage: $2,361
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $574 |
| ABBVIE INC. | 28 | $441 |
| Alkermes, Inc. | 14 | $231 |
| Corium, LLC | 14 | $227 |
| Otsuka America Pharmaceutical, Inc. | 12 | $208 |
| Axsome Therapeutics, Inc. | 14 | $181 |
| Teva Pharmaceuticals USA, Inc. | 2 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| Lundbeck LLC | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Azstarys, LYBALVI, Auvelity, UZEDY, FANAPT.
Industry payments across MI — which companies pay providers there.
